Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Hashiguchi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Immunology|January 3, 2013
CD2-mediated regulation of peripheral CD4(+)  CD25(+) regulatory T-cell apoptosis accompanied by down-regulation of BimYuji Kashiwakura, Daisuke Sakurai, Yumiko Kanno, et al.
Immunology Letters|September 28, 2011
Naïve CD4+ T cells of Peyer's patches produce more IL-6 than those of spleen in response to antigenic stimulationMasaaki Hashiguchi, Satoshi Hachimura, Akio Ametani, et al.
Cytotechnology|November 13, 2008
Splenic Dendritic Cells from Antigen-Fed Mice Induced Antigen-Specific T Cell Unresponsiveness in vivoMasanobu Hibi, Satoshi Hachimura, Toshiko Somaya, et al.
Journal of Diabetes and Its Complications|November 30, 2023
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitorSho Wakamatsu, Teruo Jojima, Masaaki Hashiguchi, et al.
Immunology|July 17, 2009
Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumoursJinhua Piao, Yosuke Kamimura, Hideyuki Iwai, et al.
Frontiers in Pharmacology|May 27, 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patientsTakeru Kashiwada, Ryotaro Takano, Fumihiko Ando, et al.
European Journal of Immunology|June 27, 2012
Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responsesTakuya Ueno, Melissa Y Yeung, Martina McGrath, et al.
Frontiers in Pharmacology|May 22, 2024
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancerFumihiko Ando, Takeru Kashiwada, Shoko Kuroda, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 12, 2025
Excessive IL-4 environment enhances osteoclastogenesis and modulates inflammatory cell differentiation in bone loss associated with food allergic enteropathyKohei Soga, Tomohiro Hoshino, Masato Tamai, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Immunology|January 3, 2013
CD2-mediated regulation of peripheral CD4(+)  CD25(+) regulatory T-cell apoptosis accompanied by down-regulation of BimYuji Kashiwakura, Daisuke Sakurai, Yumiko Kanno, et al.
Immunology Letters|September 28, 2011
Naïve CD4+ T cells of Peyer's patches produce more IL-6 than those of spleen in response to antigenic stimulationMasaaki Hashiguchi, Satoshi Hachimura, Akio Ametani, et al.
Cytotechnology|November 13, 2008
Splenic Dendritic Cells from Antigen-Fed Mice Induced Antigen-Specific T Cell Unresponsiveness in vivoMasanobu Hibi, Satoshi Hachimura, Toshiko Somaya, et al.
Journal of Diabetes and Its Complications|November 30, 2023
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitorSho Wakamatsu, Teruo Jojima, Masaaki Hashiguchi, et al.
Immunology|July 17, 2009
Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumoursJinhua Piao, Yosuke Kamimura, Hideyuki Iwai, et al.
Frontiers in Pharmacology|May 27, 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patientsTakeru Kashiwada, Ryotaro Takano, Fumihiko Ando, et al.
European Journal of Immunology|June 27, 2012
Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responsesTakuya Ueno, Melissa Y Yeung, Martina McGrath, et al.
Frontiers in Pharmacology|May 22, 2024
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancerFumihiko Ando, Takeru Kashiwada, Shoko Kuroda, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 12, 2025
Excessive IL-4 environment enhances osteoclastogenesis and modulates inflammatory cell differentiation in bone loss associated with food allergic enteropathyKohei Soga, Tomohiro Hoshino, Masato Tamai, et al.
Pageof 4